BlackRock Health Sciences Term Trust
BMEZ- Exchange
- NYSE
- SEC CIK
- 0001785971
No open-market purchases or sales by BlackRock Health Sciences Term Trust insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $255.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BlackRock Health Sciences Term Trust insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BlackRock Health Sciences Term Trust, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Xie H Erin | Other: Portfolio Manager | 0 | Feb 3, 2026 | 1 |
| Liu Xiang | Other: Portfolio Manager | 0 | Feb 3, 2026 | 1 |
| Fairbairn Robert W | Director | 0Indirect | Dec 22, 2025 | 1 |
| Saba Capital Management, L.P. | 10% Owner | 0Indirect | Apr 22, 2025 | 0 |
| Weinstein Boaz | 10% Owner | 0Indirect | Apr 22, 2025 | 0 |
| McClements Kyle | Other: Portfolio Manager | 3,664 | Feb 4, 2025 | 0 |
| Accettella Christopher | Other: Portfolio Manager | 4,509 | Feb 4, 2025 | 0 |
| Lee Jeffrey Gene | Other: Portfolio Manager | – | Feb 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 (view filing)4:17 PM ET | Nov 1-2 | 2 days | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +157.8K | $13.29 | +$2.10M | +1.4%11.8M after | 2 lots |
| Oct 31, 2023 (view filing)6:16 PM ET | Oct 30-31 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +133.5K | $13.04 | +$1.74M | +1.2%11.6M after | 2 lots |
| Oct 30, 2023 (view filing)11:01 AM ET | Oct 26-27 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +231.6K | $13.26 | +$3.07M | +2.1%11.5M after | 2 lots |
| Oct 25, 2023 (view filing)5:41 PM ET | Oct 24-25 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +377.4K | $13.41 | +$5.06M | +3.5%11.2M after | 2 lots |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Accettella ChristopherOther: Portfolio Manager | PPurchase | +333 | $15.25 | +$5.08K | +14.5%2.63K after | |
| Mar 10, 2023 (view filing) | Mar 8 | 2 days | Accettella ChristopherOther: Portfolio Manager | PPurchase | +316 | $15.87 | +$5.01K | +15.9%2.30K after | |
| Feb 8, 2022 (view filing) | Feb 4 | 4 days | Accettella ChristopherOther: Portfolio Manager | PPurchase | +1.80K | $21.86 | +$39.3K | New position1.80K after |